Published in Cancer Weekly, August 10th, 1998
The chemical, known as squalamine, "dramatically" reduces the growth of blood vessels that feed such tumors, researchers at Johns Hopkins University, Cambridge, Massachusetts, said.
Squalamine is being developed by Magainin Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania.
The researchers found that squalamine slowed the growth of brain tumors known as gliomas by 75 percent when the tumors were implanted in the sides of laboratory rats.
"Our results suggest that squalamine may...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.